Dylan Beynon, CEO of Mindbloom, talks about why he started this company, the impact of Ketamine and MDMA therapy in our society, and how this industry is just going to grow bigger in the future.
TIME-STAMPED SHOW NOTES:
[00:00] – Know more about Dylan Beynon and his company, Mindbloom
[02:30] – Why did Dylan Beynon start Mindbloom
[06:22] – Dylan Beynon talks more about MDMA therapy
[13:30] – Pricing and treatment programs that Mindbloom offer
[15:30] – Dylan Beynon’s personal opinion on MDMA and Ketamine therapy
[22:12] – The largest peer review clinical study for psychedelic and ketamine therapy
[25:20] – The best mental health tool for Dylan Beynon
[27:53] – Dylan Beynon talks about Vipassana Meditation
[36:00] – Where to find Dylan Beynon and learn more about Mindbloom
Go to https://www.marketingschool.io to learn more!
Don’t forget to help us grow by subscribing and liking on YouTube!
Leave Some Feedback:
What should we talk about next? Please let us know in the comments below
Did you enjoy this episode? If so, please leave a short review.
Connect with Us:
Single Grain << Eric’s ad agency
NP Digital << Neil’s ad agency
X @neilpatel
X @ericosiu
Discover Latest Episodes
In this episode #3004, Eric Siu and Neil Patel discuss the shift from Bing to Google and the Microsoft-OpenAI partnership’s impact on businesses. They cover how marketing agencies are evolving amid ...
In this episode #3003, Eric Siu and Neil Patel discuss MrBeast's ViewStats and the AI thumbnail backlash, Cloudflare's pay-to-play model, and how LLMs are shaping the future of SEO. They also cover th...
In this episode #3002, Eric Siu and Neil Patel discuss the collapse of Jaguar due to marketing missteps and the importance of understanding core audiences. They dive into Meta's AI acquisitions, compa...